Combination therapy with glutaminase inhibitors and immuno-oncology agents
The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
09.03.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!